Patricia Carr - May 9, 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
SVP, Chief Accounting Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Patricia Carr
Stock symbol
JAZZ
Transactions as of
May 9, 2022
Transactions value $
-$304,789
Form type
4
Date filed
5/11/2022, 05:29 PM
Previous filing
Mar 9, 2022
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale -$157K -1.06K -12.73% $148.93 7.24K May 9, 2022 Direct F1, F2
transaction JAZZ Ordinary Shares Sale -$1.66K -11 -0.15% $150.49 7.23K May 9, 2022 Direct F1
transaction JAZZ Ordinary Shares Sale -$39.4K -273 -3.78% $144.18 6.96K May 10, 2022 Direct F3
transaction JAZZ Ordinary Shares Sale -$107K -722 -10.38% $147.51 6.23K May 11, 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.11 to $144.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.51 to $147.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.